Research Builds On Positive ECHELON-1 Study in Hodgkin Lymphoma
March 18th 2020Tatyana Feldman, MD, director of T cell program at the John Theurer Cancer Center, Hackensack Meridian Health, discusses how research is now building upon the positive results from the phase III ECHELON-1 study, which was presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting.<br />
Watch
Examining the Impact of the FLAURA Trial in EGFR-Mutant NSCLC
March 14th 2020Zofia Piotrowska, MD, MHS, discusses the rationale for conducting the FLAURA trial in patients with <em>EGFR</em>-mutant non–small cell lung cancer and how the use of osimertinib impacted the treatment landscape for this patient population.
Watch
Optimizing Treatment Approaches for Hepatocellular Carcinoma
March 10th 2020David J. Pinato, MD, PhD, discusses the importance of utilizing a multidisciplinary approach when treating patients with hepatocellular carcinoma and how this approach helps optimize patient outcomes now as well as how it will help in the near future as more therapies emerge.
Watch